The 11 most recent market catalysts affecting $INSP, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 21, 2026
Corporate Catalyst
Bullish
Impact 65
Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Raises Price Target to $97
Freedom Capital Markets analyst Keith Hinton has raised the price target for Inspire Medical Systems (INSP) from $71 to $97 while maintaining a 'Buy' rating. This upgrade signals i…
Sep 11, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Buy on Inspire Medical Systems, Raises Price Target to $80
Stifel analyst Jonathan Block maintained a 'Buy' rating on Inspire Medical Systems (INSP) and raised the price target from $75 to $80. This action signals continued bullish sentime…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65
Mizuho analyst Anthony Petrone maintained an 'Outperform' rating on Inspire Medical Systems (INSP) and raised the price target from $55 to $65. This action signals a positive outlo…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 65
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target
Oppenheimer analyst Suraj Kalia upgraded Inspire Medical Systems (INSP) from a 'Perform' rating to an 'Outperform' rating, simultaneously announcing an $85 price target. This upgra…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62
Truist Securities analyst Richard Newitter reiterated a 'Hold' rating on Inspire Medical Systems (INSP) while raising the price target from $54 to $62. This action reflects a sligh…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 85
Inspire Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance. Baird and Piper Sandler raised their respective price targets on the stock.
This headline indicates a strong positive corporate catalyst for Inspire Medical Systems. Better-than-expected earnings and raised guidance directly impact investor sentiment and f…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 92
Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results
Inspire Medical Systems (INSP) delivered a strong Q2 performance, reporting earnings of $0.14 per share against an estimated loss of $0.27, and sales of $200.581 million exceeding …
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 85
Inspire Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
This headline indicates a strong positive catalyst for Inspire Medical Systems (INSP). Better-than-expected earnings and raised guidance signal robust business performance and futu…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 75
Inspire Medical Systems Announces Project Horizon Growth Plan To Generate $30M Annualized Investment Capacity; Expects $20M To $25M In Pre-Tax Restructuring Charges
This headline presents a mixed bag for Inspire Medical Systems. The 'Project Horizon Growth Plan' and '$30M Annualized Investment Capacity' suggest a strong commitment to future gr…
Aug 3, 2026
Corporate Catalyst
Bearish
Impact 85
Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $0.07-$0.62 to $(0.42)-$0.17 vs $0.90 Est
Inspire Medical Systems (INSP) has announced a significant reduction in its fiscal year 2026 GAAP EPS guidance, shifting from a previously projected positive range of $0.07-$0.62 t…
Jul 16, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $54
Truist Securities analyst Richard Newitter raised the price target for Inspire Medical Systems (INSP) from $50 to $54. This change indicates a slightly improved valuation outlook f…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.